Cargando…
Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer London
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260451/ https://www.ncbi.nlm.nih.gov/pubmed/32474884 http://dx.doi.org/10.1007/s10067-020-05184-3 |
| _version_ | 1783540316002844672 |
|---|---|
| author | Vakil-Gilani, Kiana O’Rourke, Kenneth |
| author_facet | Vakil-Gilani, Kiana O’Rourke, Kenneth |
| author_sort | Vakil-Gilani, Kiana |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7260451 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer London |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72604512020-06-01 Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19? Vakil-Gilani, Kiana O’Rourke, Kenneth Clin Rheumatol Perspectives in Rheumatology Springer London 2020-05-30 2020 /pmc/articles/PMC7260451/ /pubmed/32474884 http://dx.doi.org/10.1007/s10067-020-05184-3 Text en © International League of Associations for Rheumatology (ILAR) 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Perspectives in Rheumatology Vakil-Gilani, Kiana O’Rourke, Kenneth Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19? |
| title | Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19? |
| title_full | Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19? |
| title_fullStr | Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19? |
| title_full_unstemmed | Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19? |
| title_short | Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19? |
| title_sort | are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with covid-19? |
| topic | Perspectives in Rheumatology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260451/ https://www.ncbi.nlm.nih.gov/pubmed/32474884 http://dx.doi.org/10.1007/s10067-020-05184-3 |
| work_keys_str_mv | AT vakilgilanikiana arepatientswithrheumatologicdiseasesonchronicimmunosuppressivetherapyatlowerriskofdevelopingseveresymptomswheninfectedwithcovid19 AT orourkekenneth arepatientswithrheumatologicdiseasesonchronicimmunosuppressivetherapyatlowerriskofdevelopingseveresymptomswheninfectedwithcovid19 |